SEC Comment Letter for MYOMO, INC. (MYO) (CIK 0001369290) (MYO) — May 20, 2021
MYOMO, INC. (MYO) (CIK 0001369290)
Date: May 20, 2021 · CIK: 0001369290 · Accession: 0000000000-21-006430
AI Filing Summary & Sentiment
File numbers found in text: 333-256159
Letter
United States securities and exchange commission logo May 20, 2021 Paul R. Gudonis President and Chief Executive Officer Myomo, Inc. 137 Portland St., 4th Floor, Boston, Massachusetts 02114 Re:Myomo, Inc. Registration Statement on Form S-3 Filed May 14, 2021 File No. 333-256159 Dear Mr. Gudonis: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: James Xu
Show Raw Text
United States securities and exchange commission logo
May 20, 2021
Paul R. Gudonis
President and Chief Executive Officer
Myomo, Inc.
137 Portland St., 4th Floor,
Boston, Massachusetts 02114
Re:Myomo, Inc.
Registration Statement on Form S-3
Filed May 14, 2021
File No. 333-256159
Dear Mr. Gudonis:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: James Xu